Samlyn Capital, Llc
Source: SEC Form 13F · as of Mar 2026Samlyn Capital, Llc holds 11 biotech & pharma companies tracked by BioSniper, totaling $456.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$456.4M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 726,481 | $87.4M |
| INSMINSMED Inc | 417,205 | $68.2M |
| LLYELI LILLY & Co | 71,144 | $65.4M |
| RCUSArcus Biosciences, Inc. | 1,908,412 | $41.2M |
| DNTHDianthus Therapeutics, Inc. /DE/ | 431,115 | $36.2M |
| RVMDREVOLUTION MEDICINES, INC. | 371,948 | $36.2M |
| DYNDyne Therapeutics, Inc. | 1,922,543 | $34.9M |
| TERNTerns Pharmaceuticals, Inc. | 472,472 | $24.9M |
| GHGuardant Health Inc. | 249,137 | $23.0M |
| SYRESpyre Therapeutics, Inc. | 396,661 | $20.0M |
| NEONeoGenomics Inc. | 2,557,349 | $19.0M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.